Listed

Surgery Partners, Inc.

SGRYNasdaqCIK 1638833HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$848.9m, Q2 FY2026
Operating income$102.1m, Q2 FY2026
Net income−$15.0m, Q2 FY2026
Surgery Partners, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m674Revenue, Q3 FY2023, three months to 2023-09-30$674.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2024-11-12, accession 0001638833-24-000147.Report this figure735Revenue, Q4 FY2023, three months to 2023-12-31$735.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-02, accession 0001638833-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure717Revenue, Q1 FY2024, three months to 2024-03-31$717.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-05-12, accession 0001638833-25-000092.Report this figure762Revenue, Q2 FY2024, three months to 2024-06-30$762.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-08-05, accession 0001638833-25-000136.Report this figure770Revenue, Q3 FY2024, three months to 2024-09-30$770.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-10, accession 0001638833-25-000163.Report this figure864Revenue, Q4 FY2024, three months to 2024-12-31$864.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-02, accession 0001638833-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure776Revenue, Q1 FY2025, three months to 2025-03-31$776.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-05, accession 0001638833-26-000046.Report this figure826Revenue, Q2 FY2025, three months to 2025-06-30$826.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-10, accession 0001638833-26-000077.Report this figure822Revenue, Q3 FY2025, three months to 2025-09-30$821.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-10, accession 0001638833-25-000163.Report this figure885Revenue, Q4 FY2025, three months to 2025-12-31$885.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-02, accession 0001638833-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure811Revenue, Q1 FY2026, three months to 2026-03-31$810.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-05, accession 0001638833-26-000046.Report this figure849Revenue, Q2 FY2026, three months to 2026-06-30$848.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-10, accession 0001638833-26-000077.Report this figure
Cost of revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Operating income$m82.6Operating income, Q3 FY2023, three months to 2023-09-30$82.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0001638833-24-000147.Report this figure101Operating income, Q4 FY2023, three months to 2023-12-31$101.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-02, accession 0001638833-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure76.0Operating income, Q1 FY2024, three months to 2024-03-31$76.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-12, accession 0001638833-25-000092.Report this figure84.8Operating income, Q2 FY2024, three months to 2024-06-30$84.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-05, accession 0001638833-25-000136.Report this figure60.9Operating income, Q3 FY2024, three months to 2024-09-30$60.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001638833-25-000163.Report this figure127Operating income, Q4 FY2024, three months to 2024-12-31$127.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-02, accession 0001638833-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure61.9Operating income, Q1 FY2025, three months to 2025-03-31$61.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0001638833-26-000046.Report this figure112Operating income, Q2 FY2025, three months to 2025-06-30$111.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-10, accession 0001638833-26-000077.Report this figure106Operating income, Q3 FY2025, three months to 2025-09-30$105.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001638833-25-000163.Report this figure110Operating income, Q4 FY2025, three months to 2025-12-31$110.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-02, accession 0001638833-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure65.8Operating income, Q1 FY2026, three months to 2026-03-31$65.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0001638833-26-000046.Report this figure102Operating income, Q2 FY2026, three months to 2026-06-30$102.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-10, accession 0001638833-26-000077.Report this figure
Income tax$m3.1Income tax, Q3 FY2023, three months to 2023-09-30$3.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0001638833-24-000147.Report this figure6.0Income tax, Q4 FY2023, three months to 2023-12-31$6.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-02, accession 0001638833-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure4.4Income tax, Q1 FY2024, three months to 2024-03-31$4.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-12, accession 0001638833-25-000092.Report this figure4.9Income tax, Q2 FY2024, three months to 2024-06-30$4.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-05, accession 0001638833-25-000136.Report this figure4.5Income tax, Q3 FY2024, three months to 2024-09-30$4.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-10, accession 0001638833-25-000163.Report this figure121Income tax, Q4 FY2024, three months to 2024-12-31$120.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-02, accession 0001638833-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-05, accession 0001638833-26-000046.Report this figure(1.1)Income tax, Q2 FY2025, three months to 2025-06-30−$1.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-10, accession 0001638833-26-000077.Report this figure5.5Income tax, Q3 FY2025, three months to 2025-09-30$5.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-10, accession 0001638833-25-000163.Report this figure13.6Income tax, Q4 FY2025, three months to 2025-12-31$13.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-02, accession 0001638833-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure(1.2)Income tax, Q1 FY2026, three months to 2026-03-31−$1.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-05, accession 0001638833-26-000046.Report this figure2.6Income tax, Q2 FY2026, three months to 2026-06-30$2.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-10, accession 0001638833-26-000077.Report this figure
Net income$m(4.9)Net income, Q3 FY2023, three months to 2023-09-30−$4.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0001638833-24-000147.Report this figure(1.0)Net income, Q4 FY2023, three months to 2023-12-31−$1.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-02, accession 0001638833-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure(12.4)Net income, Q1 FY2024, three months to 2024-03-31−$12.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-12, accession 0001638833-25-000092.Report this figure(15.5)Net income, Q2 FY2024, three months to 2024-06-30−$15.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-05, accession 0001638833-25-000136.Report this figure(31.7)Net income, Q3 FY2024, three months to 2024-09-30−$31.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001638833-25-000163.Report this figure(109)Net income, Q4 FY2024, three months to 2024-12-31−$108.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-02, accession 0001638833-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure(37.7)Net income, Q1 FY2025, three months to 2025-03-31−$37.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-05, accession 0001638833-26-000046.Report this figure(2.5)Net income, Q2 FY2025, three months to 2025-06-30−$2.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001638833-26-000077.Report this figure(22.7)Net income, Q3 FY2025, three months to 2025-09-30−$22.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001638833-25-000163.Report this figure(15.0)Net income, Q4 FY2025, three months to 2025-12-31−$15.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-02, accession 0001638833-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure(35.9)Net income, Q1 FY2026, three months to 2026-03-31−$35.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-05, accession 0001638833-26-000046.Report this figure(15.0)Net income, Q2 FY2026, three months to 2026-06-30−$15.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001638833-26-000077.Report this figure
Diluted EPS$ per share(0.04)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0001638833-24-000147.Report this figurenot reported(0.10)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-12, accession 0001638833-25-000092.Report this figure(0.12)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-05, accession 0001638833-25-000136.Report this figure(0.25)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001638833-25-000163.Report this figurenot reported(0.30)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0001638833-26-000046.Report this figure(0.02)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-10, accession 0001638833-26-000077.Report this figure(0.18)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001638833-25-000163.Report this figurenot reported(0.28)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0001638833-26-000046.Report this figure(0.12)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-10, accession 0001638833-26-000077.Report this figure
Basic EPS$ per share(0.04)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.04 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0001638833-24-000147.Report this figurenot reported(0.10)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-12, accession 0001638833-25-000092.Report this figure(0.12)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-05, accession 0001638833-25-000136.Report this figure(0.25)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.25 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001638833-25-000163.Report this figurenot reported(0.30)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.30 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0001638833-26-000046.Report this figure(0.02)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-10, accession 0001638833-26-000077.Report this figure(0.18)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001638833-25-000163.Report this figurenot reported(0.28)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0001638833-26-000046.Report this figure(0.12)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-10, accession 0001638833-26-000077.Report this figure

Balance sheet

Cash and equivalents$216.7m, Q2 FY2026
Long-term debt$3.74bn, FY2025
Shareholders' equity$1.67bn, Q2 FY2026
Surgery Partners, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m236Cash and equivalents, Q3 FY2023, at 2023-09-30$236.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-07, accession 0001638833-23-000097.Report this figure196Cash and equivalents, FY2023, at 2023-12-31$195.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-07, accession 0001638833-25-000053.Report this figure185Cash and equivalents, Q1 FY2024, at 2024-03-31$185.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-07, accession 0001638833-24-000113.Report this figure214Cash and equivalents, Q2 FY2024, at 2024-06-30$213.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-06, accession 0001638833-24-000135.Report this figure222Cash and equivalents, Q3 FY2024, at 2024-09-30$221.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0001638833-24-000147.Report this figure270Cash and equivalents, FY2024, at 2024-12-31$269.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-02, accession 0001638833-26-000008.Report this figure229Cash and equivalents, Q1 FY2025, at 2025-03-31$229.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-12, accession 0001638833-25-000092.Report this figure250Cash and equivalents, Q2 FY2025, at 2025-06-30$250.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-05, accession 0001638833-25-000136.Report this figure203Cash and equivalents, Q3 FY2025, at 2025-09-30$203.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-10, accession 0001638833-25-000163.Report this figure240Cash and equivalents, FY2025, at 2025-12-31$239.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-10, accession 0001638833-26-000077.Report this figure182Cash and equivalents, Q1 FY2026, at 2026-03-31$182.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-05, accession 0001638833-26-000046.Report this figure217Cash and equivalents, Q2 FY2026, at 2026-06-30$216.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-10, accession 0001638833-26-000077.Report this figure
Current assets$m876Current assets, Q3 FY2023, at 2023-09-30$876.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-07, accession 0001638833-23-000097.Report this figure895Current assets, FY2023, at 2023-12-31$895.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-07, accession 0001638833-25-000053.Report this figure896Current assets, Q1 FY2024, at 2024-03-31$895.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-07, accession 0001638833-24-000113.Report this figure1,013Current assets, Q2 FY2024, at 2024-06-30$1.01bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-06, accession 0001638833-24-000135.Report this figure1,036Current assets, Q3 FY2024, at 2024-09-30$1.04bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0001638833-24-000147.Report this figure1,119Current assets, FY2024, at 2024-12-31$1.12bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-02, accession 0001638833-26-000008.Report this figure1,075Current assets, Q1 FY2025, at 2025-03-31$1.07bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-12, accession 0001638833-25-000092.Report this figure1,105Current assets, Q2 FY2025, at 2025-06-30$1.11bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-05, accession 0001638833-25-000136.Report this figure1,102Current assets, Q3 FY2025, at 2025-09-30$1.10bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-10, accession 0001638833-25-000163.Report this figure1,151Current assets, FY2025, at 2025-12-31$1.15bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-10, accession 0001638833-26-000077.Report this figure1,083Current assets, Q1 FY2026, at 2026-03-31$1.08bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-05, accession 0001638833-26-000046.Report this figure1,126Current assets, Q2 FY2026, at 2026-06-30$1.13bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-10, accession 0001638833-26-000077.Report this figure
Total assets$m6,780Total assets, Q3 FY2023, at 2023-09-30$6.78bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-07, accession 0001638833-23-000097.Report this figure6,877Total assets, FY2023, at 2023-12-31$6.88bn. XBRL concept us-gaap:Assets. 10-K filed 2025-03-07, accession 0001638833-25-000053.Report this figure6,976Total assets, Q1 FY2024, at 2024-03-31$6.98bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-07, accession 0001638833-24-000113.Report this figure7,489Total assets, Q2 FY2024, at 2024-06-30$7.49bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-06, accession 0001638833-24-000135.Report this figure7,534Total assets, Q3 FY2024, at 2024-09-30$7.53bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0001638833-24-000147.Report this figure7,890Total assets, FY2024, at 2024-12-31$7.89bn. XBRL concept us-gaap:Assets. 10-K filed 2026-03-02, accession 0001638833-26-000008.Report this figure7,949Total assets, Q1 FY2025, at 2025-03-31$7.95bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-12, accession 0001638833-25-000092.Report this figure7,955Total assets, Q2 FY2025, at 2025-06-30$7.95bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-05, accession 0001638833-25-000136.Report this figure7,947Total assets, Q3 FY2025, at 2025-09-30$7.95bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-10, accession 0001638833-25-000163.Report this figure8,120Total assets, FY2025, at 2025-12-31$8.12bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-10, accession 0001638833-26-000077.Report this figure8,042Total assets, Q1 FY2026, at 2026-03-31$8.04bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-05, accession 0001638833-26-000046.Report this figure8,050Total assets, Q2 FY2026, at 2026-06-30$8.05bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-10, accession 0001638833-26-000077.Report this figure
Current liabilities$m501Current liabilities, Q3 FY2023, at 2023-09-30$501.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-07, accession 0001638833-23-000097.Report this figure523Current liabilities, FY2023, at 2023-12-31$523.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-07, accession 0001638833-25-000053.Report this figure523Current liabilities, Q1 FY2024, at 2024-03-31$523.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-07, accession 0001638833-24-000113.Report this figure552Current liabilities, Q2 FY2024, at 2024-06-30$551.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-06, accession 0001638833-24-000135.Report this figure575Current liabilities, Q3 FY2024, at 2024-09-30$575.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0001638833-24-000147.Report this figure624Current liabilities, FY2024, at 2024-12-31$624.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-02, accession 0001638833-26-000008.Report this figure569Current liabilities, Q1 FY2025, at 2025-03-31$569.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-12, accession 0001638833-25-000092.Report this figure573Current liabilities, Q2 FY2025, at 2025-06-30$573.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-05, accession 0001638833-25-000136.Report this figure586Current liabilities, Q3 FY2025, at 2025-09-30$586.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-10, accession 0001638833-25-000163.Report this figure616Current liabilities, FY2025, at 2025-12-31$615.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-10, accession 0001638833-26-000077.Report this figure582Current liabilities, Q1 FY2026, at 2026-03-31$581.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-05, accession 0001638833-26-000046.Report this figure579Current liabilities, Q2 FY2026, at 2026-06-30$578.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-10, accession 0001638833-26-000077.Report this figure
Long-term debt$mnot reported2,804Long-term debt, FY2023, at 2023-12-31$2.80bn. XBRL concept us-gaap:LongTermDebt. 10-K filed 2024-02-26, accession 0001638833-24-000029.Report this figurenot reportednot reportednot reported3,405Long-term debt, FY2024, at 2024-12-31$3.40bn. XBRL concept us-gaap:LongTermDebt. 10-K filed 2025-03-07, accession 0001638833-25-000053.Report this figurenot reportednot reportednot reported3,735Long-term debt, FY2025, at 2025-12-31$3.74bn. XBRL concept us-gaap:LongTermDebt. 10-K filed 2026-03-02, accession 0001638833-26-000008.Report this figurenot reportednot reported
Shareholders' equity$m2,005Shareholders' equity, Q3 FY2023, at 2023-09-30$2.00bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-11-07, accession 0001638833-23-000097.Report this figure1,987Shareholders' equity, FY2023, at 2023-12-31$1.99bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-03-07, accession 0001638833-25-000053.Report this figure1,967Shareholders' equity, Q1 FY2024, at 2024-03-31$1.97bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-05-07, accession 0001638833-24-000113.Report this figure1,952Shareholders' equity, Q2 FY2024, at 2024-06-30$1.95bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-08-06, accession 0001638833-24-000135.Report this figure1,897Shareholders' equity, Q3 FY2024, at 2024-09-30$1.90bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0001638833-24-000147.Report this figure1,790Shareholders' equity, FY2024, at 2024-12-31$1.79bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-02, accession 0001638833-26-000008.Report this figure1,740Shareholders' equity, Q1 FY2025, at 2025-03-31$1.74bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-12, accession 0001638833-25-000092.Report this figure1,748Shareholders' equity, Q2 FY2025, at 2025-06-30$1.75bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-05, accession 0001638833-25-000136.Report this figure1,730Shareholders' equity, Q3 FY2025, at 2025-09-30$1.73bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001638833-25-000163.Report this figure1,713Shareholders' equity, FY2025, at 2025-12-31$1.71bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001638833-26-000077.Report this figure1,688Shareholders' equity, Q1 FY2026, at 2026-03-31$1.69bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-05, accession 0001638833-26-000046.Report this figure1,671Shareholders' equity, Q2 FY2026, at 2026-06-30$1.67bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001638833-26-000077.Report this figure

Cash flow

Operating cash flow$59.3m, Q2 FY2026
Capital expenditure$21.8m, Q2 FY2026
Surgery Partners, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m105Operating cash flow, Q3 FY2023, three months to 2023-09-30$104.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0001638833-24-000147. Derived: 9-month figure less the 6-month figure.Report this figure62.6Operating cash flow, Q4 FY2023, three months to 2023-12-31$62.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-02, accession 0001638833-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure40.7Operating cash flow, Q1 FY2024, three months to 2024-03-31$40.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-12, accession 0001638833-25-000092.Report this figure82.8Operating cash flow, Q2 FY2024, three months to 2024-06-30$82.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-05, accession 0001638833-25-000136. Derived: 6-month figure less the 3-month figure.Report this figure65.2Operating cash flow, Q3 FY2024, three months to 2024-09-30$65.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001638833-25-000163. Derived: 9-month figure less the 6-month figure.Report this figure111Operating cash flow, Q4 FY2024, three months to 2024-12-31$111.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-02, accession 0001638833-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure6.0Operating cash flow, Q1 FY2025, three months to 2025-03-31$6.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001638833-26-000046.Report this figure81.3Operating cash flow, Q2 FY2025, three months to 2025-06-30$81.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-10, accession 0001638833-26-000077. Derived: 6-month figure less the 3-month figure.Report this figure83.6Operating cash flow, Q3 FY2025, three months to 2025-09-30$83.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001638833-25-000163. Derived: 9-month figure less the 6-month figure.Report this figure103Operating cash flow, Q4 FY2025, three months to 2025-12-31$103.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-02, accession 0001638833-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure11.7Operating cash flow, Q1 FY2026, three months to 2026-03-31$11.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001638833-26-000046.Report this figure59.3Operating cash flow, Q2 FY2026, three months to 2026-06-30$59.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-10, accession 0001638833-26-000077. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m18.9Capital expenditure, Q3 FY2023, three months to 2023-09-30$18.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0001638833-24-000147. Derived: 9-month figure less the 6-month figure.Report this figure19.8Capital expenditure, Q4 FY2023, three months to 2023-12-31$19.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-02, accession 0001638833-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure21.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$21.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-12, accession 0001638833-25-000092.Report this figure26.9Capital expenditure, Q2 FY2024, three months to 2024-06-30$26.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-05, accession 0001638833-25-000136. Derived: 6-month figure less the 3-month figure.Report this figure20.2Capital expenditure, Q3 FY2024, three months to 2024-09-30$20.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001638833-25-000163. Derived: 9-month figure less the 6-month figure.Report this figure22.3Capital expenditure, Q4 FY2024, three months to 2024-12-31$22.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-02, accession 0001638833-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure22.7Capital expenditure, Q1 FY2025, three months to 2025-03-31$22.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-05, accession 0001638833-26-000046.Report this figure23.4Capital expenditure, Q2 FY2025, three months to 2025-06-30$23.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-10, accession 0001638833-26-000077. Derived: 6-month figure less the 3-month figure.Report this figure19.8Capital expenditure, Q3 FY2025, three months to 2025-09-30$19.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001638833-25-000163. Derived: 9-month figure less the 6-month figure.Report this figure12.8Capital expenditure, Q4 FY2025, three months to 2025-12-31$12.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-02, accession 0001638833-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure16.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$16.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-05, accession 0001638833-26-000046.Report this figure21.8Capital expenditure, Q2 FY2026, three months to 2026-06-30$21.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-10, accession 0001638833-26-000077. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)128.82m, Q2 FY2026
Surgery Partners, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares88.9Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3088,907,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-07, accession 0001638833-23-000097.Report this figure125Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31125,206,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-07, accession 0001638833-24-000113.Report this figure127Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30127,370,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-06, accession 0001638833-24-000135.Report this figure126Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30125,747,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0001638833-24-000147.Report this figure126Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31125,972,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-12, accession 0001638833-25-000092.Report this figure126Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30126,134,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-05, accession 0001638833-25-000136.Report this figure126Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30126,172,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001638833-25-000163.Report this figure127Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31126,602,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0001638833-26-000046.Report this figure127Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30126,980,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-10, accession 0001638833-26-000077.Report this figure127Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30127,206,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001638833-25-000163.Report this figure128Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31128,367,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0001638833-26-000046.Report this figure129Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30128,825,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-10, accession 0001638833-26-000077.Report this figure

Shares outstanding: 130.92mShares outstanding, period not labelled, at 2026-08-03130,918,260 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-10, accession 0001638833-26-000077.Report this figure at Aug 3, 2026, from the cover of the 10-Q filed Aug 10, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. Listed shows no prices and gives no investment advice.